Free Trial
NASDAQ:CUTR

Cutera (CUTR) Stock Price, News & Analysis

$0.69
-0.05 (-6.78%)
(As of 09/6/2024 ET)
Today's Range
$0.68
$0.75
50-Day Range
$0.66
$1.67
52-Week Range
$0.65
$10.37
Volume
320,619 shs
Average Volume
1.09 million shs
Market Capitalization
$13.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.33

Cutera MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
676.3% Upside
$5.33 Price Target
Short Interest
Bearish
21.79% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($4.74) to ($3.96) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.93 out of 5 stars

Computer And Technology Sector

523rd out of 594 stocks

Electromedical Equipment Industry

19th out of 22 stocks

CUTR stock logo

About Cutera Stock (NASDAQ:CUTR)

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

CUTR Stock Price History

CUTR Stock News Headlines

Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Why Are Hedge Funds Shorting Cutera, Inc. (CUTR)?
Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Cutera® Announces AviClear® Investor Webinar
See More Headlines
Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2024
Today
9/07/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/04/2025

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CUTR
Employees
460
Year Founded
1998

Price Target and Rating

Average Stock Price Target
$5.33
High Stock Price Target
$10.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+676.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-162,830,000.00
Pretax Margin
-87.52%

Debt

Sales & Book Value

Annual Sales
$169.19 million
Book Value
($10.72) per share

Miscellaneous

Free Float
20,014,000
Market Cap
$13.81 million
Optionable
Optionable
Beta
1.32

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Michael A. Karavitis Ph.D. (Age 54)
    Executive VP & Chief Technology Officer
    Comp: $595.8k
  • Mr. Taylor C. Harris (Age 48)
    President, CEO & Director
  • Mr. Stuart Drummond
    Interim Chief Financial Officer
  • Mr. Jeffrey S. Jones (Age 68)
    Chief Operating Officer
  • Mr. Charles G. Thier (Age 61)
    Chief Information Officer
    Comp: $620.84k
  • Anne Werdan
    Director of Investor Relations
  • Dr. Stephana E. Patton J.D. (Age 53)
    Ph.D., Chief Legal Officer
  • Mr. Steve Kreider
    Senior Vice President of Global Marketing
  • Mr. Brent Hauser (Age 47)
    President of International

CUTR Stock Analysis - Frequently Asked Questions

How have CUTR shares performed this year?

Cutera's stock was trading at $3.53 at the start of the year. Since then, CUTR shares have decreased by 80.5% and is now trading at $0.6870.
View the best growth stocks for 2024 here
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) released its quarterly earnings results on Thursday, August, 8th. The medical device company reported ($1.23) EPS for the quarter, topping analysts' consensus estimates of ($1.55) by $0.32. The medical device company earned $34.38 million during the quarter, compared to the consensus estimate of $39.47 million.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Cutera's major shareholders?

Cutera's top institutional shareholders include Gabelli Funds LLC (1.68%), Bank of Montreal Can (1.41%), Sculptor Capital LP and Squarepoint Ops LLC (0.57%). Insiders that own company stock include Taylor C Harris, David H Mowry, Stuart Drummond, Michael Karavitis, Rohan Seth, Timothy J Oshea and Katherine S Zanotti.
View institutional ownership trends
.

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA) and DocuSign (DOCU).

This page (NASDAQ:CUTR) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners